Background
==========

Purines such as adenosine triphosphate (ATP) and adenosine are known to act as neurotransmitters as well as neuromodulators in the central, peripheral, and enteric nervous system \[[@B1],[@B2]\].

The pharmacological actions of adenosine on smooth-muscle preparations are well established, and the effects are mediated via receptors that have been classified as P~1~-purinoceptors (adenosine receptors) \[[@B3]\]. The adenosine receptors may be subdivided into A~1~and A~2~adenosine receptors, based on their functional coupling to adenyl cyclase activity \[[@B4]\]. Thus, A~1~receptors are generally linked to inhibition of cyclic adenosine monophosphate (cAMP) generation, while A~2~receptors stimulate the formation of cAMP \[[@B5]\]. In addition, an A~3~adenosine receptor with inhibitory effect on cAMP formation has been cloned \[[@B6]\], and the A~2~receptor has been further subdivided into the A~2A~and A~2B~receptor subtypes on a molecular basis \[[@B4]\]. Using either ligand binding, functional studies, or molecular techniques, A~1~, A~2A~, A~2B~, and A~3~receptors have been identified within the rat small intestine \[[@B7]-[@B10]\].

A~1~receptors in the rat ileum are known to be situated on cholinergic nerve endings innervating the smooth muscle, and activation of these A~1~receptors reduces smooth-muscle contraction following electrical stimulation, by reducing acetylcholine (ACH) release \[[@B9]-[@B12]\]. However, there is also strong evidence that in the circular layer of the rat ileum, the smooth muscle can be relaxed by A~1~receptor-mediated mechanisms \[[@B9]\]. In contrast, the A~2A~receptor increases electrically induced twitch contractions in the guinea-pig ileum, which is attributed to facilitation of ACH release \[[@B13]\].

Within the peristaltic reflex, ACH and tachykinins (substance P, neurokinin A) are responsible for the ascending excitatory motor response of the peristaltic reflex activated by cholinergic interneurons (nicotinic receptors) \[[@B14]-[@B16]\], whereas vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and nitric oxide are responsible for the descending relaxant pathway \[[@B17],[@B18]\].

Various models of the enteric reflex have been described, such as cut-open gut segments that are stimulated by stretching oral and aboral to the recording site \[[@B15],[@B19]\], or intact gut segments stimulated either by increasing intraluminal pressure or by electrical stimulation, either with intraluminal pressure being recorded or with force transducers being connected to the serosal surface \[[@B20],[@B21]\]. In our laboratory, a myenteric reflex model has been developed that uses whole segments of rat ileum. Intrinsic nerves are stimulated by electrical stimulation, and motility changes are detected by force transducers attached to record the activity of the circular muscle \[[@B22]-[@B24]\]. The pharmacology of the reflex response induced by electrical stimulation as used in our experiments has been shown to be similar to that activated by intraluminal balloon dilatation \[[@B25]\].

With various experimental set-ups designed for investigation of the peristaltic reflex, there have been reports of involvement of adenosine receptors in small-intestinal peristalsis. However, due to the different experimental set-ups used, the differing outcome variables, and the variety of agonists and antagonists used, a number of contradictory results have been published. Whereas the peristaltic reflex model concentrates on the initiation of the peristaltic reflex, measuring propulsion and contraction of the longitudinal smooth muscle, the model investigating the myenteric reflex focuses on ascending and descending neural pathways, measuring contraction of the circular smooth muscle.

Since most investigations have described possible influences of single adenosine receptor subtypes, the aim of the present study was to characterize a possible role of adenosine A~1~, A~2A~, A~2B~and A~3~receptors in the ascending and descending myenteric reflex in the rat ileum in vitro.

Results
=======

Characterization of the set-up used to investigate the ascending excitatory and descending inhibitory reflexes
--------------------------------------------------------------------------------------------------------------

Electrical field stimulation caused an ascending contraction and a descending relaxation, which was followed by a subsequent contractile response (Fig. [1](#F1){ref-type="fig"}). All motility responses caused by electrical field stimulation were abolished by TTX (3 × 10^-^7 M: oral contraction: -3.9 ± 4.5%\*; anal relaxation: -6.4 ± 4.5%\*; anal contractile response: -0 ± 0.0%\*; \*= *P*\< 0.05; n = 5) as well as hexamethonium (10^-4^M: oral contraction: -0 ± 0.0%\*; anal relaxation: -9.8 ± 4.7%\*; anal contractile response: -0 ± 0.0%\*; \*= *P*\< 0.05; n = 5). Blockade of muscarinic receptors with atropine (10^-6^M) decreased the oral and anal contraction (atropine 10^-6^M: oral: -6.2 ± 4.7%\*, n = 8; anal: -13.6 ± 10.9%\*, n = 5), whereas the anal relaxation was significantly increased by cholinergic blockade (10^-6^M: +221.2 ± 82.4%\*, n = 6).

![Representative tracings showing the effect of the A~1~-receptor agonist CPA and the A~1~-receptor antagonist DPCPX on the (a) ascending excitatory reflex response and (b) descending relaxant reflex response in the rat ileum. The reflex response was induced by electrical stimulation (EFS; 20 V, 2 ms, 3 pps, 15 s), and the response was recorded by contractility recording 2 cm oral from the stimulation site. (1 cm pen deflection distance = 6 mN)](1471-2202-3-21-1){#F1}

None of the adenosine receptor agonists or antagonists used had any influence on the basal activity of the ileum preparation -- either on basal tone or on the occurrence of spontaneous contractions (data not shown).

Effect of the A~1~agonist CPA and the A~1~antagonist DPCPX
----------------------------------------------------------

On the ascending contraction CPA (10^-14^--10^-8^M) caused an increase in the contraction force at lower concentrations and a decrease at the highest concentration applied (n = 17) (Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). On the descending relaxation, CPA caused a concentration-dependent reduction (n = 17) (Figs [1](#F1){ref-type="fig"},[3](#F3){ref-type="fig"}). The latency of the ascending contraction was significantly increased by CPA (Table [1](#T1){ref-type="table"}).

![Concentration-response curves of the different adenosine receptor agonists (a) and antagonists (b) on the excitatory ascending reflex response. The reflex response was induced by electrical stimulation (EFS; 20 V, 2 ms, 3 pps, 15 s), and the response was recorded by contractility recording 2 cm oral from the stimulation site (\* = *P*\< 0.05 for CPA/MRS 1191; + = *P*\< 0.05 for CGS 21680/DPCPX; \$ = *P*\< 0.05 for IB-MECA/Alloxazine).](1471-2202-3-21-2){#F2}

![Concentration-response curves of the different adenosine receptor agonists (a) and antagonists (b) on the inhibitory descending reflex response. The reflex response was induced by electrical stimulation (EFS; 20 V, 2 ms, 3 pps, 15 s), and the response was recorded by contractility recording 2 cm aboral from the stimulation site (\* = *P*\< 0.05 for CPA/MRS 1191; + = *P*\< 0.05 for CGS 21680/DPCPX; \$ = *P*\< 0.05 for IB-MECA/Alloxazine; § = *P*\< 0.05 for ZM 341285).](1471-2202-3-21-3){#F3}

###### 

An overview of the influence of the different adenosine receptor agonists/antagonists used on the latency of the ascending contraction. The influence on latency is given for the highest concentration applied

  Drug                     Experiments (n)   Mean ± SEM   Significance
  ------------------------ ----------------- ------------ --------------
  DPCPX 10^-6^M            10                134 ± 14%    *P*\< 0.05
  CPA 10^-8^M              16                171 ± 22%    *P*\< 0.05
  ZM 241385 10^-6^M        16                106 ± 6%     n.s.
  CGS 21680 3 × 10^-7^M    11                104 ± 9%     n.s.
  Alloxazine 3 × 10^-7^M   9                 104 ± 7%     n.s.
  MRS 1191 10^-7^M         11                113 ± 15%    n.s.
  IB-MECA 3 × 10^-7^M      8                 111 ± 14%    n.s.

DPCPX (10^-10^--10^-6^M) also caused a concentration-dependent reduction in the ascending contraction (n = 11) (Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). The descending relaxation was significantly reduced by DPCPX (n = 11) (Figs [1](#F1){ref-type="fig"},[3](#F3){ref-type="fig"}). The latency of the ascending contraction was significantly increased by DPCPX (Table [1](#T1){ref-type="table"}).

Effect of the A~2A~agonist CGS 21680 and the A~2A~antagonist ZM 241385
----------------------------------------------------------------------

CGS 21680 (10^-10^-3 × 10^-7^M) reduced the ascending contraction and the descending relaxation in a concentration-dependent fashion (n = 11) (Figs. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}), whereas the latency of the ascending contraction remained unchanged (Table [1](#T1){ref-type="table"}).

The A~2A~receptor antagonist ZM 241385 (10^-10^--10^-7^M) did not significantly change the ascending contraction (n = 17) (Fig. [2](#F2){ref-type="fig"}), descending relaxation (Fig. [3](#F3){ref-type="fig"}), or the latency of the ascending contraction (Table [1](#T1){ref-type="table"}).

Effect of the A~2B~antagonist alloxazine
----------------------------------------

Alloxazine (10^-10^-3 × 10^-7^M) caused a small but significant increase in the ascending contractile response (n = 8) (Fig. [2](#F2){ref-type="fig"}) and a significant decrease in the descending relaxation (n = 8) (Fig. [3](#F3){ref-type="fig"}), whereas the latency of the ascending relaxation was not significantly changed (Table [1](#T1){ref-type="table"}).

Effect of the A~3~agonist IB-MECA and the A~3~antagonist MRS 1191
-----------------------------------------------------------------

IB-MECA (10^-10^-3 × 10^-7^M) reduced the ascending contraction in a concentration-dependent fashion (n = 8) (Fig. [2](#F2){ref-type="fig"}) and reduced the descending relaxation (Fig. [3](#F3){ref-type="fig"}), whereas the latency of the ascending relaxation was not significantly changed (Table [1](#T1){ref-type="table"}).

MRS 1191 (10^-14^--10^-7^M) caused a significant decrease in the ascending contraction (n = 12) (Fig. [2](#F2){ref-type="fig"}) and descending relaxation (Fig. [3](#F3){ref-type="fig"}), whereas the latency of the ascending relaxation was not significantly changed (Table [1](#T1){ref-type="table"}).

Discussion
==========

Since the release of adenosine 5\'-triphosphate from isolated myenteric nerve varicosities was first demonstrated in the guinea-pig small intestine in 1982 \[[@B29]\], it has been postulated that endogenous purines are involved in the neural enteric reflex pathways.

The data presented in this study demonstrate involvement of the A~1~adenosine receptor in the myenteric reflex of the rat small intestine. The ascending contractile response is increased by the A~1~agonist CPA at lower concentrations, whereas it is attenuated at higher concentrations. This finding is different compared to studies focused on the peristaltic reflex and peristalsis, in which activation of A~1~receptors causes an attenuation of the ascending contraction in guinea-pig ileum \[[@B30]\] or a decrease in peristalsis in rat jejunum \[[@B31]\] but direct comparison in this case is hampered by the different setups, different species and the different and higher agonist concentration used. The experimental set-up used in the present study also showed an attenuation of the ascending contractions, but only at high concentrations -- an effect that may be nonspecific, whereas at lower concentrations the effect of CPA has to be regarded as a specific A~1~receptor-mediated effect.

Interestingly, the A~1~receptor antagonist DPCPX also attenuated the ascending contractile response in our experiments, an observation that is in agreement with the finding that CPA increases the ascending contractile response in this set-up at the more specific lower concentrations. Since in the present experimental set-up, the A~1~receptor antagonist DPCPX when given alone also attenuates the myenteric reflex responses, these data suggest that activation of A~1~receptors by endogenously released adenosine under our experimental conditions stimulates the myenteric reflex responses. The fact that the specific A~1~antagonist DPCPX was able to attenuate the reflex response in the preparations used contrasts with the findings of Hancock and Coupar \[[@B31]\]. Using a different preparation, with reflex stimulation by fluid inflation and recording of longitudinal muscle contraction and of volume expulsion, they were unable to find any influence of the A~1~antagonist DPCPX on the peristaltic reflex response \[[@B31]\]. This difference might be due to different experimental set-ups (electrical vs. fluid inflation), to the use of different muscle layers to record contractile activity (longitudinal vs. circular smooth muscle), or possibly to the fact that different regions were investigated (ileum vs. jejunum). These differences limit a comparison on the few published attempts investigating components of the peristaltic reflex.

Both the A~1~receptor agonist and the antagonist caused significant decreases in descending relaxation. In addition, the latency of the ascending contraction appears to be modulated by the A~1~receptor, since activation by CPA causes an increase in the timing of the occurrence of the ascending contraction after electrical stimulation. Interestingly, the latency of the ascending contraction was also increased in the presence of DPCPX. A possible explanation for this might be that exogenously applied agonists cause activation of mechanisms that may not be activated by endogenous adenosine receptor agonists under physiological conditions.

Alloxazine, the selective A~2B~receptor antagonist, provides further evidence for a modulatory involvement of endogenous adenosines on the myenteric reflex. In the presence of alloxazine, the ascending contractile response and the descending relaxant response following initiation of the myenteric reflex are both reduced. In contrast to the A~1~receptor, which appears to modulate the myenteric reflex permanently after being activated through endogenous adenosines, the A~2B~receptor antagonist does not influence the latency of the ascending contraction. The timing of the ascending contractions is also not influenced by agonists or antagonists of either the A~2A~or A~3~receptors, making a physiological role for these receptors in the timing of the myenteric reflex unlikely, but giving further strength to the specificity of A~1~receptor involvement in the timing of the myenteric reflex.

The A~2A~receptor agonist caused attenuation of both ascending contraction and descending relaxation within the myenteric reflex response. However, since the A~2A~receptor antagonist did not exert any effects on the ileum preparation, this finding may not reflect a physiological pathway within the myenteric reflex under the experimental conditions used here and furthermore an effect of CGS 21680 on other than A~2A~receptors (e.g. A~1~receptors) can not be ruled out.

The effects observed with the receptor agonist and antagonist for the A~3~receptor might only be pharmacological ones, although the effect of the A~3~receptor antagonist might reflect the fact that endogenous adenosines within the myenteric reflex also act via the A~3~receptor. Since both agonists and antagonists show attenuation of either the ascending contraction or the descending relaxation, these findings may reflect involvement of these receptor subtypes, but nonspecific actions cannot be completely ruled out.

All of the above considerations are reflected by a number of observations reported in the literature, but there are many limitations to the interpretation of adenosine receptor-mediated effects in a complex physiological system such as the myenteric reflex. Especially the fact that the selectivity of the different agonists and antagonists used is limited might limit the conclusions drawn when the effects at higher concentrations are discussed. Since the agonist and antagonist selectivity is based on rank orders, effects on other receptors can not be ruled out for the higher concentrations and therefore the conclusions were drawn very carefully and effects at the lower concentrations were regarded as more specific.

Adenosine A~1~and A~2~receptors within the gastrointestinal tract are known to reduce ACH release, as well as tachykinin (substance P) release, from neuronal endings \[[@B32],[@B33]\]. However, adenosine receptors not only influence neurotransmitter release, but are also potent in modulating neuron excitability \[[@B34]\], and adenosine released from neuronal endings have been thought to represent relaxant neurotransmitters in the gastrointestinal tract, with direct actions on smooth muscle \[[@B35]-[@B37]\].

With regard to rat ileum, A~1~receptor agonists in whole segments of rat ileum cause relaxation of the longitudinal muscle in which NECA and CPA are equipotent, although it is known that NECA is a weak A~1~receptor agonist that also has a high agonist potency on A~2~receptors \[[@B9]\]. Isolated longitudinal ileal muscle is also relaxed by A~1~receptor activation, but in contrast to whole segments, CPA is more potent than NECA \[[@B9]\]. In contrast, isolated circular muscle is contracted, and the potency order again suggests that an A~1~receptor is involved \[[@B9]\]. This difference in A~1~receptor-mediated effects on circular and longitudinal smooth muscle is very important, and may explain the differences in motility changes reported in studies investigating peristaltic or myenteric reflex pathways.

At present, most of the available agonists and antagonists are characterized by a rank order of receptor activity that makes interpretation of the findings in a complex in-vitro experiment difficult, and implies that effects at lower concentrations may be regarded as more specific than effects obtained at higher concentrations. Antagonist-on-agonist application experiments were not carried out in the present set-up, since results obtained from such experiments would be hard to interpret in a complex arrangement such as that used here, in which adenosine receptors are located at more than one site. Interpretation is made even more difficult by the ability of adenosine receptors to interact with other receptors for neurotransmitters/neuromodulators. This extends the range of opportunities for adenosine receptor agonists to interfere with neuronal function and communication \[[@B8]\].

Comparisons with reports by other investigators focusing on the peristaltic reflex are hampered not only by the fact that each investigator uses a different set-up and evaluates different patterns of the peristaltic reflex (contraction force vs. contraction occurrence), but also by the fact that either agonists or antagonists of the adenosine receptors are used, and that most of the investigations focus only on a single adenosine receptor subtype, instead of the broad spectrum of all receptor subtypes \[[@B10],[@B21],[@B38]-[@B40]\]. An even greater problem in interpreting the effects of adenosine agonists and antagonists in a complex experimental set-up such as the peristaltic reflex is the fact that fairly specific agonists and antagonists, acting on a variety of adenosine receptor subtypes in a large number of possible involved locations (neuronal and muscular), can only be interpreted as the sum of actions that might result from a large number of activating and inactivating effects at different sites. Though all of the above mentioned limitations also account for the here presented study, this is the first attempt to completely workout all adenosine receptor subtypes in one and the same setup.

Conclusion
==========

In conclusion, the results presented here provide evidence that the adenosine receptors participate in the peristaltic reflex in a complex manner. A~1~receptors appear to modulate the timing physiologically, whereas for the A~2A~, A~2B~, and A~3~receptors, no evidence was found that they are involved in the timing of the peristaltic reflex. The study also demonstrates that A~1~receptors are physiologically involved in the regulation of the force of ascending contraction in the myenteric part of the peristaltic reflex, with A~1~receptor activation causing an increase in the ascending contraction and an attenuation of the descending relaxation. A~2B~receptors appear to be physiologically involved in the regulation of the ascending contraction of the myenteric reflex pathways, with A~2B~receptor blockade causing an increase in the ascending contraction and an attenuation of the descending relaxation.

Methods
=======

Male Wistar rats (300--400 g) were killed by intraperitoneal injection of pentobarbital sodium (100 mg/kg). The ileum was removed immediately and kept in oxygenated Krebs-Ringer bicarbonate solution (KRS: NaCl 115.5 mM, MgSO~4~1.16 mM, NaH~2~PO~4~1.16 mM, glucose 11.1 mM, NaHCO~3~21.9 mM, CaCl~2~2.5 mM, KCl 4.16 mM). All experiments lasted less than 3 h, and each muscle strip was used for a single concentration-response curve only. Experiments were carried out in accordance with institutional animal ethics committee guidelines.

Myenteric reflex
----------------

The experiments investigating the myenteric reflex were carried out in an in-vitro organ bath model, as described previously \[[@B24]\], modified from similar models used before \[[@B20],[@B25],[@B26]\]. A segment 10 cm in length was carefully dissected, and the mesenteric arcade was removed. The segment was placed in an organ bath filled with 35 ml oxygenated KRS and maintained at 37°C. A glass rod 2 mm in diameter was passed through the lumen, and fixed the gut in the organ bath. Mechanical activity of the circular muscle was recorded using force-displacement transducers attached with tips to the serosa 2 cm orally and 2 cm anally from the pair of stimulation electrodes and a tension of 1 g was applied. Contractile changes were recorded using Grass FTO3C force transducers (Grass, Quincy, MA, USA) and recorded on a Sensormedics R611 chart recorder (Sensormedics, Anaheim, CA, USA). Field stimulation impulses for neuronal responses were applied using a Grass S11 stimulator, stimulating for 15 s at intervals of 2 min at standard parameters of 20 V pulse strength and 3 Hz, 2 ms pulse duration. The electrical stimulatory signal was connected to an AC/DC coupler and recorded simultaneously with the motility signal.

The gut segment was stimulated every 2 min, and this periodic stimulation was maintained throughout the experiment. A stable response to the electrical stimulation (identical contractions to at least three consecutive stimuli) was established after 10--20 minutes. When the response stabilized, a stable response was achieved for a minimum of 3 hours and control experiments to a maximum period of 5 hours were performed as described formerly. The experiment was started after an equilibration period of 30 min. Drugs were added 60 s after the last stimulation and before the next electrical stimulation in the organ bath so that all of the tissue was equilibrated with each drug. For each concentration, at least three reflex responses were elicited before the next concentration was tested. Concentration-response curves were recorded in a cumulative manner. At the end of the experimental protocol, the buffer was exchanged several times, and after a period of 15 min a control recording was performed after the wash-out.

Drugs
-----

The drugs used were N^6^-cyclopentyladenosine (CPA), 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), alloxazine, 4-\[2-\[\[6-amino-9-(N-ethyl-b-D-ribofuranuroamidosyl)-9H-purin-2-yl\]amino\]ethyl\]benzenepropanoic acid (CGS 21680), ZM 241385, MRS 1191, IB-MECA (RBI, Natick, MA, USA), N^G^-nitro-L-arginine-methyl-ester (L-NAME), atropine, hexamethonium, tetrodotoxin (TTX) (Sigma, Irvine, UK). Drugs were freshly dissolved and further diluted in KRS on the day of use. DPCPX, alloxazine, CGS 21680, ZM 241385, MRS 1191 and IB-MECA were soluble in dimethyl sulfoxide (DMSO) and further diluted in KRS. Control experiments investigating DMSO at the highest concentration applied and performed in a time course comparable to the other experiments had no effect on the recorded motility. References for the pharmacological profiles of the used drugs can be found at Fredholm et al., 2001 and Liang et al. 1995 \[[@B27],[@B28]\].

Data evaluation and analysis
----------------------------

As a measure of the contractile activity, the area under the curve (mm^2^) of the contraction induced at the oral recording sites and the relaxation at the aboral recording sites were determined using a digitizing tablet (Sigma Scan, Jandel, CA, USA) and changes in the area under the curve in presence of drugs are expressed in % of pre-drug controlls. The latency of the reflex response (seconds) was determined as the time interval between the start of stimulation and the onset of contraction, and expressed as a percentage change in comparison with the pre-drug control.

Data are given as mean plus or minus standard error (m ± SEM); n indicates the number of independent observations in ileal segments from different animals. Using a commercial statistical package (SigmaStat, Jandel Scientific, San Rafael, CA, USA), analysis of variance for repeated measures was used to test for a statistical difference, and the Dunnett post-hoc test was used to establish the significance against the control value. A null hypothesis with a probability of less than 5% was considered significant.
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